There were 125 press releases posted in the last 24 hours and 454,374 in the last 365 days.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages LivePerson (LPSN) Investors with Substantial Losses to Contact Firm, Firm Investigating Possible Securities Law Violations

/EIN News/ -- SAN FRANCISCO, March 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges LivePerson, Inc. (NASDAQ: LPSN) investors who suffered substantial losses to submit your losses now.

Contact An Attorney Now:

LivePerson, Inc. (LPSN) Investigation:

The investigation focuses on LivePerson’s disclosures concerning its WildHealth business, which the company acquired in Feb. 2022.

Specifically, LivePerson recently assured investors that it “expect[ed] strong performance by WildHealth […] in the fourth quarter” and has repeatedly assured investors that its financial controls and procedures are effective.

LivePerson’s statements first came into question on Feb. 28, 2023, when the company announced it would not timely file its annual financial report. The company explained that it “requires more time to perform additional review and testing of revenue recognition with respect to a recently discontinued WildHealth program, for which Medicare reimbursement is suspended[.]”

Then, on Mar. 15, 2023, LivePerson reported dismal Q4 2022 financial results and a weak 2023 outlook. The company revealed that in Nov. 2022, WildHealth received a notice that Medicare was suspending reimbursements for services rendered under the Medicare demonstration program. LivePerson also announced it recorded a reserve for revenue associated with WildHealth services delivered under the program during Q4 2022.

On Mar. 16, 2023, LivePerson filed its annual financial report and revealed that there are material weaknesses in its internal control over financial reporting related to its WildHealth subsidiary transactions.

These events sent the price of LivePerson shares sharply lower.

“We’re focused on investors’ losses and whether LivePerson may have misled investors about whether WildHealth was providing reimbursable services under the Medicare program,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in LivePerson and have substantial losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding LivePerson should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at Follow the firm for updates and news at @ClassActionLaw.

Reed Kathrein, 844-916-0895

Primary Logo